Computer-aided auscultation

Bat-Call's Revolutionary AI Based Infra-sound Auscultation Technology to Fight COVID-19

Retrieved on: 
Wednesday, April 1, 2020

Inaccurate auscultation can result in suboptimal patient care, unnecessary exams and increased healthcare costs.

Key Points: 
  • Inaccurate auscultation can result in suboptimal patient care, unnecessary exams and increased healthcare costs.
  • A technology that can monitor low frequencies of lung sounds can better detect and monitor deterioration or improvement of the disease.
  • Bat-Call was founded in 2016 by a team of visionary industry experts with the mission of enhancing primary diagnostics for health care professionals and patients with the world's first AI based infra-sound auscultation technology.
  • Together with the AI based classifier, the Voqx analyzes the sounds to enhance patient diagnosis.

eMurmur receives CE mark certification for its heart murmur detection solution

Retrieved on: 
Wednesday, June 12, 2019

OTTAWA, June 12, 2019 /PRNewswire/ - eMurmur announced today that its flagship "eMurmur ID" solution has received the CE mark certification.

Key Points: 
  • OTTAWA, June 12, 2019 /PRNewswire/ - eMurmur announced today that its flagship "eMurmur ID" solution has received the CE mark certification.
  • eMurmur ID is a mobile and cloud solution which operates in conjunction with a 3rdparty electronic stethoscope.
  • It uses advanced machine learning to identify and classify pathologic and innocent heart murmurs, the absence of a heart murmur, and S1, S2 heart sounds.
  • eMurmur launched an early access program available at https://emurmur.com/clinical , designed to give early adopters full access to eMurmur ID.

FDA grants clearance for a heart murmur detection solution on a personal mobile device

Retrieved on: 
Tuesday, May 14, 2019

OTTAWA, May 14, 2019 /PRNewswire/ -eMurmur today announced that its flagship "eMurmur ID" solution has received FDA clearance, enabling a new era in heart murmur detection.

Key Points: 
  • OTTAWA, May 14, 2019 /PRNewswire/ -eMurmur today announced that its flagship "eMurmur ID" solution has received FDA clearance, enabling a new era in heart murmur detection.
  • eMurmur ID is a mobile and cloud solution which operates in conjunction with a 3rdparty electronic stethoscope.
  • It uses advanced machine learning to identify and classify pathologic and innocent heart murmurs, the absence of a heart murmur, and S1, S2 heart sounds.
  • The end-to-end solution is comprised of AI-based analytics, a mobile app, and a web portal (all HIPAA compliant).